Work

Urinalysis and perceived effects following 2-week use of a commercial broad-spectrum cannabidiol product.

Year: 2024

Type: article

Abstract: < .05), which remained significant after correcting for possible confounds (i.e., age, sex, dosage). No adverse events were reported. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

Source: Experimental and Clinical Psychopharmacology

DOI: 10.1037/pha0000747

Authors: Ivori Zvorsky, Justyna Kulpa, Laszlo L. Mechtler, Christopher C. Ralyea, Jeffrey Lombardo, A. C. Del Re, Marcel O. Bonn-Miller

Institutions: Charlotte's Web (United States), Dent Neurologic Institute, University at Buffalo, State University of New York

Language: English

Topic: Cannabis and Cannabinoid Research

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4404140838

FWCI: 0.235

Cites:

Cited by: 1

Related to: 10